HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
81.36
+1.45 (1.81%)
At close: Apr 14, 2026, 4:00 PM EDT
81.36
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:20 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
The 14 analysts that cover HealthEquity stock have a consensus rating of "Buy" and an average price target of $115, which forecasts a 41.35% increase in the stock price over the next year. The lowest target is $89 and the highest is $128.
Price Target: $115 (+41.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 4 |
| Buy | 8 | 9 | 9 | 9 | 8 | 9 |
| Hold | 2 | 2 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 15 | 15 | 15 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Hold → Buy Upgrades $85 → $105 | Hold → Buy | Upgrades | $85 → $105 | +29.06% | Apr 9, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $120 → $128 | Strong Buy | Maintains | $120 → $128 | +57.33% | Mar 19, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $125 → $110 | Buy | Maintains | $125 → $110 | +35.20% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $129 → $123 | Buy | Maintains | $129 → $123 | +51.18% | Mar 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $100 | Buy | Maintains | $110 → $100 | +22.91% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
1.43B
from 1.31B
Increased by 8.57%
Revenue Next Year
1.55B
from 1.43B
Increased by 8.42%
EPS This Year
4.67
from 2.46
Increased by 89.83%
EPS Next Year
5.39
from 4.67
Increased by 15.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 1.5B | 1.7B | |
| Avg | 1.4B | 1.5B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 13.1% | 16.1% | |
| Avg | 8.6% | 8.4% | |
| Low | 4.8% | 2.4% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 4.97 | 6.28 | |
| Avg | 4.67 | 5.39 | |
| Low | 4.46 | 5.00 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 101.9% | 34.5% | |
| Avg | 89.8% | 15.4% | |
| Low | 81.3% | 7.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.